355 related articles for article (PubMed ID: 18609357)
1. Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension.
Scioscia M; Paine MA; Gumaa K; Rodeck CH; Rademacher TW
J Matern Fetal Neonatal Med; 2008 Aug; 21(8):581-5. PubMed ID: 18609357
[TBL] [Abstract][Full Text] [Related]
2. Inositol phosphoglycan P-type in healthy and preeclamptic pregnancies.
Scioscia M; Gumaa K; Whitten M; Selvaggi LE; Rodeck CH; Rademacher TW
J Reprod Immunol; 2007 Dec; 76(1-2):85-90. PubMed ID: 17493685
[TBL] [Abstract][Full Text] [Related]
3. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels.
Kunjara S; Greenbaum AL; Wang DY; Caro HN; McLean P; Redman CW; Rademacher TW
Mol Genet Metab; 2000 Feb; 69(2):144-58. PubMed ID: 10720442
[TBL] [Abstract][Full Text] [Related]
4. Preeclampsia, insulin signalling and immunological dysfunction: a fetal, maternal or placental disorder?
Rademacher TW; Gumaa K; Scioscia M
J Reprod Immunol; 2007 Dec; 76(1-2):78-84. PubMed ID: 17537518
[TBL] [Abstract][Full Text] [Related]
5. Placental localization and expression of the cell death factors BNip3 and Nix in preeclampsia, intrauterine growth retardation and HELLP syndrome.
Stepan H; Leo C; Purz S; Höckel M; Horn LC
Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):172-6. PubMed ID: 16219518
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2.
Scioscia M; Gumaa K; Kunjara S; Paine MA; Selvaggi LE; Rodeck CH; Rademacher TW
J Clin Endocrinol Metab; 2006 Feb; 91(2):709-17. PubMed ID: 16332940
[TBL] [Abstract][Full Text] [Related]
7. Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus.
Scioscia M; Gumaa K; Selvaggi LE; Rodeck CH; Rademacher TW
J Perinat Med; 2009; 37(5):469-71. PubMed ID: 19492925
[TBL] [Abstract][Full Text] [Related]
8. Placental prostate-specific antigen content in preeclampsia.
Can M; Acikgoz S; Guven B; Ozmen Bayar U
Acta Biochim Pol; 2012; 59(3):367-9. PubMed ID: 22855719
[TBL] [Abstract][Full Text] [Related]
9. Inositol phosphoglycans and preeclampsia: from bench to bedside.
Scioscia M; Williams PJ; Gumaa K; Fratelli N; Zorzi C; Rademacher TW
J Reprod Immunol; 2011 May; 89(2):173-7. PubMed ID: 21549431
[TBL] [Abstract][Full Text] [Related]
10. Inositol phosphoglycan P-type in infants of preeclamptic mothers.
Scioscia M; Robillard PY; Hall DR; Rademacher LH; Williams PJ; Rademacher TW
J Matern Fetal Neonatal Med; 2012 Feb; 25(2):193-5. PubMed ID: 21401313
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of aquaporin 1 in placenta, placental membranes and peritoneum of patients with hypertensive disorder complicating pregnancy].
Li LX; Liu YL; Wen JG; Li ZZ; Zhao YP
Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):497-501. PubMed ID: 19080511
[TBL] [Abstract][Full Text] [Related]
12. Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus.
Scioscia M; Kunjara S; Gumaa K; Gomez Galan AM; McLean P; Rodeck CH; Rademacher TW
Gynecol Obstet Invest; 2007; 64(4):217-23. PubMed ID: 17664885
[TBL] [Abstract][Full Text] [Related]
13. Proteasomal activity in placentas from women with preeclampsia and intrauterine growth restriction: implications for expression of HIF-alpha proteins.
Rajakumar A; Michael HM; Daftary A; Jeyabalan A; Gilmour C; Conrad KP
Placenta; 2008 Mar; 29(3):290-9. PubMed ID: 18222538
[TBL] [Abstract][Full Text] [Related]
14. Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies.
Schiessl B; Strasburger C; Bidlingmaier M; Mylonas I; Jeschke U; Kainer F; Friese K
Arch Gynecol Obstet; 2006 Jun; 274(3):150-4. PubMed ID: 16532320
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of inositol phosphoglycan P-type in gestational diabetes mellitus.
Scioscia M; Kunjara S; Gumaa K; McLean P; Rodeck CH; Rademacher TW
Diabet Med; 2007 Nov; 24(11):1300-4. PubMed ID: 17956457
[TBL] [Abstract][Full Text] [Related]
16. Inositol phosphoglycan putative insulin mediator in human amniotic fluid.
Scioscia M; Vimercati A; Selvaggi LE; Rodeck CH; Rademacher TW
J Matern Fetal Neonatal Med; 2006 Jan; 19(1):9-12. PubMed ID: 16492584
[TBL] [Abstract][Full Text] [Related]
17. Placental insulin and insulin-like growth factor I receptors in normal and preeclamptic pregnancies.
Díaz E; Cárdenas M; Ariza AC; Larrea F; Halhali A
Clin Biochem; 2005 Mar; 38(3):243-7. PubMed ID: 15708546
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia.
Holdsworth-Carson SJ; Lim R; Mitton A; Whitehead C; Rice GE; Permezel M; Lappas M
Placenta; 2010 Mar; 31(3):222-9. PubMed ID: 20045185
[TBL] [Abstract][Full Text] [Related]
19. P-type inositol phosphoglycans in serum and amniotic fluid in active pre-eclampsia.
Paine MA; Scioscia M; Gumaa KA; Rodeck CH; Rademacher TW
J Reprod Immunol; 2006 Apr; 69(2):165-79. PubMed ID: 16384607
[TBL] [Abstract][Full Text] [Related]
20. Placental pathology in pregnancy-induced hypertension (PIH) with or without intrauterine growth retardation.
Jain K; Kavi V; Raghuveer CV; Sinha R
Indian J Pathol Microbiol; 2007 Jul; 50(3):533-7. PubMed ID: 17883125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
